Risk factors of the origin and progression of diabetic retinopathy

Česká verzia

Authors: Peter Jackuliak ¹; Dagmar Bucková ²; Miroslav Helbich ³
Authors place of work: V. interná klinika Lekárskej fakulty UK a Univerzitnej nemocnice Bratislava, prednosta prof. MUDr. Juraj Payer, PhD., FRCP ¹; Novartis Slovakia s. r. o., Bratislava ²; Caldera s. r. o, Banská Štiavnica ³
Published in the journal: Forum Diab 2015; 4(3): 185-190
Category: Main Theme: Review

Summary

Nowadays we see the global trend of a growing number of diabetic patients. The number of patients is increasing in Slovakia as well. Diabetic retinopathy (DR) is the second most common microvascular complications and a leading cause of blindness in individuals with diabetes mellitus (DM). The keystone for the better management of patients is the understanding of the risk factors responsible for the development and progression of diabetic retinopathy. The results of previously published studies are not consistent. Common conclusion of these studies is proven impact of the duration and type of DM, HbA_1c, and blood pressure on DR development only. More knowledge in this area could bring new epidemiological studies with sufficient number of patients, quality design and a comprehensive ophthalmic and diabetic examination. This paper presents an overview of existing knowledge about the risk factors of diabetic retinopathy and their progression and the expected benefits of the project DIARET SK.

Key words:
diabetes mellitus – diabetic retinopathy – diabetic macular edema – epidemiological – study prevalence

Zdroje

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010: 87(1): 4–14.

2. Národné centrum zdravotníckych informácií. Činnosť diabetologických ambulancií v SR 2012. NCZI 2013 (11). Dostupné z WWW: <http://www.nczisk.sk/Documents/publikacie/2012/zs1311.pdf>.

3. Fong DS, Aiello LP, Ferris FL. Diabetic retinopathy. Diabetes Care 2004; 27(10): 2540–2553.

4. Wu L, Fernandez-Loaiza P, Sauma J et al. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes 2013; 4(6): 290–294.

5. Williams R, Airey M, Baxter H et al. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye (Lond) 2004; 18(10): 963–983.

6. Omar AF, Silva PS, Sun JK. Genetics of diabetic retinopathy. Semin Ophthalmol 2013; 28(5–6): 337–346.

7. Klein R, Knudtson MD, Lee KE et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII. The Twenty-Five-Year Incidence of Macular Edema in Persons with Type 1 Diabetes. Ophthalmology 2009; 116(3): 497–503.

8. Kempen JH, O’Colmain BJ, Leske MC et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004; 122(4): 552–563.

9. Ruta LM, Magliano DJ, Lemesurier R et al. Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabet Med 2013; 30(4): 387–398.

10. Yau JW, Rogers SL, Kawasaki R et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35(3): 556–564.

11. Zhang X, Saaddine JB, Chou CF et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010; 304(6): 649–656.

12. Henricsson M, Nystrom L, Blohme G et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003; 26(2): 349–354.

13. Rodriguez-Poncelas A, Miravet-Jiménez S, Casellas A et al. Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain). Br J Ophthalmol 2015. Dostupné z DOI: <http://dx.doi.org/10.1136/bjophthalmol-2015–306683>.

14. Cheung N, Wang JJ, Klein R et al. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care 2007; 30(7): 1742–1746.

15. Lamoureux EL, Wong TY. Diabetic Retinopathy in 2011: Further Insights From New Epidemiological Studies and Clinical Trials. Diabetes Care 2011; 34(4): 1066–1067.

16. Nathan DM. DCCT/EDIC Research Group. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview. Diabetes Care 2014; 37(1): 9–16.

17. Adler AI, Stratton IM, Neil HA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br Med J 2000; 321 7258): 412–419.

18. Olafsdottir E, Anderson DKG, Dedorsson I et al. The prevalence of retinopathy in subjects with and without type 2 diabetes mellitus. Acta Ophthalmol 2014; 92(2): 133–137.

19. Charuvedi N, Sjolie AK, Stephenson JM et al. Effect of lisinopriol on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinipril in Insulin-Dependent Diabetes Mellitus. Lancet 1998; 351(9095): 28–31.

20. Mauer M, Zinman B, Gardiner R et al. Renal and retinal effects of enalapril and losartan in type1 diabetes. N Engl J Med 2009; 361(1): 40–51.

21. Estacio R, Jeffers BW, Gifford N et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000; 23(Suppl 2): B54-B64.

22. Cetin EN, Bulgu Y, Ozdemir S et al. Association of serum lipid levels with diabetic retinopathy. Int J Ophthalmol 2013; 6(3): 346–349.

23. Abhary S, Hewitt AW, Burdon KP et al. A Systematic Meta-Analysis of Genetic Association Studies for Diabetic Retinopathy. Diabetes 2009; 58(9): 2137–2147.

24. Kuo JZ, Wong TY, Rotter JI. Challenges in Elucidating the Genetics of Diabetic Retinopathy. JAMA Ophthalmol 2014; 132(1): 96–107.

25. Looker HC, Nelson RG, Chew E et al. Looker HC et al. Genome-wide linkage analyses to identify loci for diabetic retinopathy. Diabetes 2007; 56(4): 1160–1166.

26. Kaidonis G, Abhary S, Daniell M et al. Genetic study of diabetic retinopathy: recruitment methodology and analysis of baseline characteristics. Clin Experiment Ophthalmol 2014; 42(5): 486–493.

27. Vodrážková E, Šefčiková S, Helbich M. Psychometrická validácia verzie „dotazníka zrakových funkcíí-25 v podmienkach Slovenska“. Čes a Slov Oftal 2012; 68(3): 102–108.